Skip to main content
Displaying 37 - 47 of 47
Display:
12
24
48
Cirrhosis & Complications
5
Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
4
Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Cirrhosis & Complications
6
Grifols: Extending the treatment paradigm for cirrhosis: long-term albumin administration and beyond - The International Liver Congress™ 2019
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Page
3
Current page
4
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy